Vasculitis & polymyalgia rheumatica

Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

Enhanced B cells might contribute to the pathogenesis of TAK, and serum IgG levels could serve as a simple, useful biomarker to assess disease activity and monitor treatment response in TAK.

Study context

Population
Newly diagnosed patients with TAK, compared with systemic lupus erythematosus (SLE) patients and healthy controls
Participants
98 / 31 / 60
Exposure
Newly diagnosed TAK vs SLE vs healthy controls
  • TAKn = 98
  • SLEn = 31
  • Healthy controls (HCs)n = 60reference
Outcome
Peripheral B cells and serum Ig
Methodological detailscomparative with SLE and HCs, 6-month follow-up after immunotherapy, immunohistochemical staining of aortic tissue
  • Comparative with SLE and HCs
  • 6-month follow-up after immunotherapy
  • Immunohistochemical staining of aortic tissue

Main finding

As reported in the abstract

  • Proportion of peripheral CD3-CD19+ B cells and serum IgG lower in TAK than in SLE, but higher than in HCs
  • CD3-CD19+ B cell counts higher in TAK than in HCs
  • Serum IgG and IgG1 higher in active TAK than in non-active TAK
  • In TAK, serum IgG positively correlated with erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Kerr score, ITAS2010 and ITAS-A before immunotherapy
  • After 6 months of immunotherapy, serum immunoglobulin (Ig) levels significantly decreased; changes in IgG positively correlated with ESR, CRP, Kerr score and ITAS-A
  • Immunohistochemistry confirmed CD19+ B cell and IgG infiltration of the aortic wall in TAK

Observational data: associations, not effects.

Original publication

Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis. Clin Exp Rheumatol. Published 2 July 2022. doi:10.55563/clinexprheumatol/98s4q1

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.